(Q36040337)

11 August 2017

Immunotherapy for acute myelogenous leukaemia (English)

1 reference

11 August 2017

1 reference

1 reference

Powles RL

1

1 reference

11 August 2017

Crowther D

2

1 reference

11 August 2017

Bateman CJ

3

1 reference

11 August 2017

Beard ME

4

1 reference

11 August 2017

McElwain TJ

5

1 reference

11 August 2017

Russell J

6

1 reference

11 August 2017

Lister TA

7

1 reference

11 August 2017

Whitehouse JM

8

1 reference

11 August 2017

Wrigley PF

9

1 reference

11 August 2017

Pike M

10

1 reference

11 August 2017

Alexander P

11

1 reference

11 August 2017

Fairley GH

12

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1973

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

28

1 reference

11 August 2017

365-376

1 reference

11 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1973.162

11 August 2017

0 references

cites work

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigenicity of the Tumour

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Recognition of leukaemia cells as foreign before and after autoimmunization.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous Leukaemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsiveness.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Management of adult acute myelogenous leukaemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Acute myelocytic leukemia in adults.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Immunotherapy for acute myelogenous leukaemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2008928

Leukapheresis by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML)

23 September 2018

1 reference

12 December 2020

Approaches to the immunological treatment of cancer in man

1 reference

12 December 2020

Autoimmunization with irradiated tumour cells in human malignant melanoma

1 reference

12 December 2020

Demonstration of cell-mediated immunity to human neoplasms of various histological types

1 reference

12 December 2020

Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

1 reference

12 December 2020

Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults

1 reference

12 December 2020

Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence, and prognosis

1 reference

12 December 2020

The role of the reticuloendothelial system in the host reaction to neoplasia

1 reference

12 December 2020

AN IMMUNOLOGICAL METHOD OF INCREASING THE SENSITIVITY OF PRIMARY SARCOMAS TO LOCAL IRRADIATION WITH X RAYS

1 reference

12 December 2020

Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1973.162

1 reference

11 August 2017

1 reference

11 August 2017

1 reference